News & Events


Pillar Biosciences to Collaborate with Illumina on Next-Generation Sequencing Based In Vitro Diagnostics Development

Illumina and Pillar Biosciences, Inc. today announced an agreement to develop next-generation sequencing (NGS) based in vitro diagnostic (IVD) tests. Under the terms of the …

Read More →

ORI Healthcare Fund Invests in Pillar Biosciences

HONG KONG, CHINA—(Marketwired – May 11, 2016) – ORI Healthcare Fund L.P. (ORI Fund) announces the completion of US$18 million investment into Pillar Biosciences Inc., …

Read More →


Sorry, we couldn't find any posts. Please try a different search.

Scroll to Top